Michele Biscuola Selected Research

Michele Biscuola Research Topics

Disease

10	Neoplasms (Cancer) 11/2022 - 05/2011
4	Endometrial Neoplasms (Endometrial Cancer) 11/2016 - 02/2013
3	Breast Neoplasms (Breast Cancer) 08/2016 - 01/2012
3	Carcinosarcoma 05/2013 - 01/2011
2	Carcinoma (Carcinomatosis) 11/2022 - 11/2016
2	Microsatellite Instability 05/2021 - 11/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 01/2014
2	Hypertension (High Blood Pressure) 01/2019 - 09/2007
2	Atherosclerosis 01/2009 - 01/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2007 - 01/2006
1	Lobular Carcinoma 11/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 05/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 05/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2019
1	Neutropenia 01/2019
1	Lymphatic Metastasis 08/2016
1	Endometrioid Carcinoma 11/2013
1	Thymoma (Thymic Carcinoma) 05/2013
1	Neuroblastoma 05/2013
1	Testicular Neoplasms (Testicular Cancer) 02/2013
1	Neoplasm Metastasis (Metastasis) 02/2013
1	Rheumatoid Arthritis 05/2011
1	Autoimmune Diseases (Autoimmune Disease) 05/2011
1	Chronic Disease (Chronic Diseases) 05/2011
1	Crohn Disease (Crohn's Disease) 05/2011
1	Ulcerative Colitis 05/2011
1	Vascular Diseases (Vascular Disease) 01/2009
1	Dyslipidemias (Dyslipidemia) 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2008
1	Inflammation (Inflammations) 04/2008
1	Pathologic Constriction (Stenosis) 09/2007
1	Peripheral Arterial Disease 09/2007
1	Myocardial Infarction 01/2006

Drug/Important Bio-Agent (IBA)

3	Cadherins (E-Cadherin)IBA 11/2022 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 11/2016 - 01/2009
3	MicroRNAs (MicroRNA)IBA 02/2013 - 01/2011
2	Formaldehyde (Formol)FDA Link 05/2021 - 04/2020
2	ParaffinIBA 05/2021 - 04/2020
2	ErbB Receptors (EGF Receptor)IBA 04/2020 - 05/2013
1	CateninsIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 04/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Streptonigrin (Nigrin)IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	EndoglinIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	BilirubinIBA 01/2019
1	PerforinIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Exonucleases (3' 5' Exonuclease)IBA 11/2016
1	Estrogens (Estrogen)FDA Link 06/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2015
1	AntibodiesIBA 01/2014
1	OsteonectinIBA 11/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2013
1	ErbB-2 ReceptorIBA 05/2013
1	Proto-Oncogene Proteins c-metIBA 05/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2013
1	methionylmethionine (Met-Met)IBA 05/2013
1	Anaplastic Lymphoma KinaseIBA 05/2013
1	Peptides (Polypeptides)IBA 05/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2013
1	AntigensIBA 02/2013
1	Complementary DNA (cDNA)IBA 02/2013
1	ClaudinsIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Estrogen ReceptorsIBA 01/2012
1	Immunomodulating AgentsIBA 05/2011
1	CarcinogensIBA 05/2011
1	CytokinesIBA 01/2009
1	LipidsIBA 01/2009
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2008
1	Arachidonic Acid (Vitamin F)IBA 04/2008
1	Triglycerides (Triacylglycerol)IBA 09/2007
1	Phenobarbital (Luminal)FDA Link 09/2007
1	Adenosine Diphosphate (ADP)IBA 09/2007
1	LDL Receptors (LDL Receptor)IBA 01/2006

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2011
1	Adjuvant Chemotherapy 05/2021
1	Aftercare (After-Treatment) 08/2016
1	Neoadjuvant Therapy 08/2016
1	Immunomodulation 05/2011